Diagnostic immunology in celiac disease

Area of Science:

• Immunology
• Gastroenterology
• Autoimmune Disorders

Background:

• Celiac disease is an autoimmune disorder affecting ~1% of populations in Western and Middle-Eastern regions.
• Serum autoantibodies to transglutaminase and endomysium are key biomarkers in celiac disease.
• Accurate diagnosis of celiac disease is critical for patient management.

Purpose of the Study:

• To review recent publications on celiac autoantibody testing.
• To focus on the clinical applications of celiac autoantibody detection.
• To discuss the limitations of celiac autoantibody testing in routine practice.

Main Methods:

• Literature review of recent publications.
• Analysis of studies focusing on celiac autoantibody assays.
• Evaluation of diagnostic performance in clinical settings.

Main Results:

• Autoantibodies to transglutaminase and endomysium are highly prevalent in celiac disease patients.
• These autoantibodies are crucial for celiac disease diagnosis.
• Recent studies offer insights into optimizing antibody testing protocols.

Conclusions:

• Celiac autoantibody testing is fundamental for diagnosing celiac disease.
• Understanding the applications and limitations of these tests is vital for effective clinical use.
• Continued research is needed to refine diagnostic strategies for celiac disease.